Patents Assigned to CONVERGANCE PHARMACEUTICALS LIMITED
  • NOVEL COMPOUNDS
    Publication number: 20150119404
    Abstract: The invention relates to spiro derivatives, to the use of said derivatives in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation.
    Type: Application
    Filed: May 22, 2013
    Publication date: April 30, 2015
    Applicant: CONVERGANCE PHARMACEUTICALS LIMITED
    Inventors: Gerard M.P. Giblin, David T. Macpherson, David R. Witty, Steven J. Stanway